SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Torii Pharmaceutical Co., Ltd (TRXPF)

TRXPF RSS Feed
Add TRXPF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 3/31/2016 5:35:19 PM - Followers: 0 - Board type: Free - Posts Today: 0
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products primarily in Japan. The company’s products include REMITCH agent for the treatment of pruritus in hemodialysis patients; Truvada and Stribild antiretroviral agent used for the treatment of HIV-1 infection in adults; ANTEBATE, an agent used for the treatment of the inflammatory manifestations of dermatosis; FUTHAN, an agent used for the prevention of blood coagulation during extracorporeal circulation and for the treatment of acute pancreatitis and disseminated intravascular coagulation; and Riona, an agent used for the enhancement of hyperphosphatemia in patients with chronic kidney disease; KAYEXALATE, an agent used for the enhancement of hyperkalemia caused by acute and chronic renal failure; and URINORM, an agent used for the treatment of hyperuricemia and gout. Its products for skin diseases and allergens comprise Dovonex, an agent used for the treatment of psoriasis vulgaris; ZEFNART, a topical antifungal agent used for the treatment of tinea, including tinea pedis; and LOCOID, an agent used to treat the inflammatory manifestations of dermatosis. Torii Pharmaceutical Co., Ltd. markets and sells its products through medical representatives in Japan. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRXPF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
No posts yet. Be the first!